Biomarkers can be defined as indicators of any biologic state,
and they are central to the future of medicine. As the cost of
developing drugs has risen in recent years, reducing the number
of new drugs approved for use, biomarker development may be a way
to cut costs, enhance safety, and provide a more focused and
rational pathway to drug development.
On October 24, 2008, the IOM's Forum on Drug Discovery,
Development, and... more...